306 related articles for article (PubMed ID: 22535241)
1. Myeloid-derived suppressor cells in transplantation and cancer.
Ochando JC; Chen SH
Immunol Res; 2012 Dec; 54(1-3):275-85. PubMed ID: 22535241
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells: natural regulators for transplant tolerance.
Boros P; Ochando JC; Chen SH; Bromberg JS
Hum Immunol; 2010 Nov; 71(11):1061-6. PubMed ID: 20705113
[TBL] [Abstract][Full Text] [Related]
3. The roles of myeloid-derived suppressor cells in transplantation.
Wu T; Zhao Y; Zhao Y
Expert Rev Clin Immunol; 2014 Oct; 10(10):1385-94. PubMed ID: 25119260
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells: linking inflammation and cancer.
Ostrand-Rosenberg S; Sinha P
J Immunol; 2009 Apr; 182(8):4499-506. PubMed ID: 19342621
[TBL] [Abstract][Full Text] [Related]
5. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
Fernández A; Oliver L; Alvarez R; Fernández LE; Lee KP; Mesa C
Hum Vaccin Immunother; 2014; 10(11):3251-60. PubMed ID: 25483674
[TBL] [Abstract][Full Text] [Related]
6. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity.
Youn JI; Gabrilovich DI
Eur J Immunol; 2010 Nov; 40(11):2969-75. PubMed ID: 21061430
[TBL] [Abstract][Full Text] [Related]
7. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S; Bronte V; Mandruzzato S
J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
[TBL] [Abstract][Full Text] [Related]
8. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.
Veltman JD; Lambers ME; van Nimwegen M; Hendriks RW; Hoogsteden HC; Aerts JG; Hegmans JP
BMC Cancer; 2010 Aug; 10():464. PubMed ID: 20804550
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cells in transplantation.
Dilek N; van Rompaey N; Le Moine A; Vanhove B
Curr Opin Organ Transplant; 2010 Dec; 15(6):765-8. PubMed ID: 20881494
[TBL] [Abstract][Full Text] [Related]
10. Polarization and reprogramming of myeloid-derived suppressor cells.
Yang WC; Ma G; Chen SH; Pan PY
J Mol Cell Biol; 2013 Jun; 5(3):207-9. PubMed ID: 23532593
[TBL] [Abstract][Full Text] [Related]
11. Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.
Albeituni SH; Ding C; Yan J
Cancer J; 2013; 19(6):490-501. PubMed ID: 24270348
[TBL] [Abstract][Full Text] [Related]
12. Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation.
Ochando J; Conde P; Utrero-Rico A; Paz-Artal E
Front Immunol; 2019; 10():374. PubMed ID: 30894860
[TBL] [Abstract][Full Text] [Related]
13. [Myeloid-derived suppressor cells - the new mechanism of immunosuppression in cancer].
Luczyński W; Krawczuk-Rybak M; Stasiak-Barmuta A
Postepy Hig Med Dosw (Online); 2008 Jan; 62():18-22. PubMed ID: 18219264
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cell heterogeneity in human cancers.
Solito S; Marigo I; Pinton L; Damuzzo V; Mandruzzato S; Bronte V
Ann N Y Acad Sci; 2014 Jun; 1319():47-65. PubMed ID: 24965257
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming of myeloid-derived suppressor cells in the context of organ transplantation.
Iske J; Cao Y; Roesel MJ; Shen Z; Nian Y
Cytotherapy; 2023 Aug; 25(8):789-797. PubMed ID: 37204374
[TBL] [Abstract][Full Text] [Related]
16. Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity.
Schroeter A; Roesel MJ; Matsunaga T; Xiao Y; Zhou H; Tullius SG
Front Immunol; 2022; 13():917972. PubMed ID: 35874716
[TBL] [Abstract][Full Text] [Related]
17. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site.
Haverkamp JM; Crist SA; Elzey BD; Cimen C; Ratliff TL
Eur J Immunol; 2011 Mar; 41(3):749-59. PubMed ID: 21287554
[TBL] [Abstract][Full Text] [Related]
18. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
Li H; Han Y; Guo Q; Zhang M; Cao X
J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
[TBL] [Abstract][Full Text] [Related]
19. Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells.
Nagaraj S; Gabrilovich DI
Semin Cancer Biol; 2012 Aug; 22(4):282-8. PubMed ID: 22313876
[TBL] [Abstract][Full Text] [Related]
20. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
